GlassScriptPhysician profile
Douglas Jason Rivera
NPI 1073583274
$5,956.52
in general payments reported to CMS, 2019-2025
53 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $319 · 2021: $245 · 2022: $1,774 · 2023: $2,332 · 2024: $313 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,268 · Travel and Lodging: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,267.50 |
| Travel and Lodging | $833.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $1,319.76 | 2022-2023 | |
| Boston Scientific Corporation | $1,038.34 | 2022-2025 | Spaceoar Vue System - 10ml, Lithovue |
| Janssen Biotech, INC. | $750.72 | 2019-2024 | Tecvayli, Darzalex, Carvykti |
| Accuray Incorporated | $368.65 | 2022-2023 | Tomo Therapy System |
| Bayer Healthcare Pharmaceuticals INC. | $213.47 | 2022-2025 | |
| Reflexion Medical, INC. | $213.00 | 2023 | Reflexion Medical Radiotherapy System |
| Novartis Pharmaceuticals Corporation | $189.60 | 2019-2024 | |
| Medtronic, INC. | $148.15 | 2022 | |
| Stryker Corporation | $133.33 | 2022-2023 | |
| Covidien LP | $96.42 | 2019 | |
| Taiho Oncology, INC. | $96.33 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $83.97 | 2021-2025 | Tagrisso, Imfinzi |
| Amgen INC. | $74.91 | 2019-2023 | Xgeva, Vectibix, Nplate |
| Pfizer INC. | $74.37 | 2019-2024 | |
| Blue Earth Diagnostics | $73.65 | 2019-2021 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $65.03 | 2019 | |
| Amag Pharmaceuticals, INC. | $59.13 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $58.79 | 2023 | Keytruda |
| Morphosys, US INC. | $52.89 | 2022-2023 | Monjuvi |
| Seagen INC. | $50.16 | 2020-2023 | Padcev |
| Rigel Pharmaceuticals, INC. | $43.72 | 2022-2023 | Tavalisse, Rezlidhia |
| Ipsen Biopharmaceuticals, INC | $40.44 | 2019-2022 | |
| Astellas Pharma US INC | $40.40 | 2023-2024 | Xospata, Xtandi |
| Sumitomo Pharma America, INC. | $39.29 | 2023-2024 | Orgovyx |
| Icotec Medical INC. | $35.84 | 2025 | Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Abbvie INC. | $32.71 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $32.45 | 2019-2020 | |
| Emd Serono, INC. | $31.84 | 2020-2021 | |
| Exelixis INC. | $30.32 | 2020-2023 | Cabometyx |
| Jazz Pharmaceuticals INC. | $28.03 | 2023 | |
| Karyopharm Therapeutics INC. | $27.17 | 2021-2023 | Xpovio |
| Mirati Therapeutics, INC. | $26.71 | 2024 | Krazati |
| Lilly USA, LLC | $24.08 | 2022 | |
| Srs Medical Systems, INC. | $24.04 | 2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Progenics Pharmaceuticals, INC. | $23.72 | 2025 | |
| Myriad Genetic Laboratories, INC. | $23.62 | 2025 | Myrisk |
| Genentech USA, INC. | $23.36 | 2024 | Venclexta |
| Apellis Pharmaceuticals, INC. | $22.96 | 2022 | |
| Eusa Pharma (US) LLC | $20.98 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.12 | 2022 | |
| Servier Pharmaceuticals LLC | $20.07 | 2023 | |
| G1 Therapeutics, INC. | $19.44 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.90 | 2020 | |
| Celgene Corporation | $17.58 | 2022 | |
| Organon LLC | $17.50 | 2022 | |
| Blueprint Medicines Corporation | $17.27 | 2022 | |
| Stemline Therapeutics INC. | $16.88 | 2023 | Orserdu |
| Dova Pharmaceuticals | $14.17 | 2021 | |
| Octapharma USA, INC. | $13.12 | 2022 | |
| Adaptive Biotechnologies Corporation | $13.03 | 2022 | |
| Genzyme Corporation | $12.81 | 2020 | |
| Macrogenics, INC. | $12.16 | 2022 | |
| Allergan, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.